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iew diagnostic tools and creative treatments have sparked
n exciting evolution in medicine. Although this would
eem to be a positive change, sometimes we adopt these new
ools with not enough thought to ensure quality. Who is
esponsible for this apparent short-sightedness? Can we
urn quality from an endgame to the consistent kick-off of
are?
In a recent Washington Post editorial, internist Stephen
oolf found that the U.S. spends “far more money on
nventing new treatments than on research into how to
eliver them” (1). Woolf contends that this focus on
edical breakthroughs is, in fact, costing lives. “Failing to
stablish systems to ensure that everyone receives recom-
ended care is causing greater disease and deaths at levels
hat can rarely be offset by medical advances,” he wrote.
onabedian (2) sounded a similarly dire note, saying that
there’s lip service to quality. . .but real commitment is in
hort supply.”
There is no question that imaging, in particular, has
orever changed the way cardiologists practice medicine.
he New England Journal of Medicine, for example, called it
ne of the top 11 medical developments of the past 1,000
ears (3). Imaging offers the opportunity for earlier, better,
nd more accurate diagnosis of cardiovascular disease and
he prospect of better quality care.
Yet, the striking growth in the use of cardiovascular
iagnostic imaging, at a rate of 26% per year from 1993 to
002 (4), has been accompanied by a frustrating combina-
ion of inconsistent usage, lack of rigorous controls, and
ittle measurable impact on outcomes. We must admit that
e are falling short when it comes to quality in imaging, and
t is time to recommit to implementing quality standards to
chieve improved patient outcomes.
The task before us is not simple. The barriers to quality
ardiovascular imaging include a very limited knowledge
ase and a system not driven by a “scientific method”
pproval process, which would include randomized control
rials and “hard” patient outcomes. Even diagnostic accuracy
s not consistently evaluated before widespread clinical use.
here is spotty information on costs and limited consensus
n quality standards. In fact, if imaging were a drug, given
he current evidence base, regulatory approval would prob-
bly be denied. aDespite the lack of regulatory pressure, it is important
hat the American College of Cardiology (ACC) and the
edical community recommit to improving imaging quality.
e must develop pragmatic research methodologies and
maging standards for clinical trials. We must better define
maging quality and outcomes. And we must focus on
mproving imaging effectiveness, efficacy, and efficiency in
ur clinical practices.
The ACC is working closely with other professional
ocieties, payers, and regulators to jump-start efforts to
mprove quality in imaging. Our existing quality efforts,
rom ACC/American Heart Association clinical guidelines
o performance measures that rarely address imaging, make
t clear that different tools are needed. Step-by-step how-to
rograms, such as GAP and CathKit, are designed to bridge
he gap between guidelines and application by bringing
uality to the point of care.
Ordering the right test for the right patient is an
mportant component of quality in imaging, and we are
eveloping a set of novel appropriateness criteria for cardio-
ascular imaging. This groundbreaking effort resulted in the
elease last fall of Appropriateness Criteria for Single-
hoton Emission Computed Tomography Myocardial Per-
usion Imaging (SPECT MPI). Task forces are already
nderway on appropriateness criteria for cardiac computed
omography and cardiac magnetic resonance, to be followed
y echocardiography. The ACC hopes to have these new
riteria completed and published in 2006.
Although these efforts are an important step in the right
irection, they alone are not enough. Quality in imaging
ill require us to adopt new processes for quality improve-
ent. We must put in place a thorough and thoughtful
rocess for measuring quality that begins before a patient
alks in the door.
We must apply appropriateness criteria to patient selec-
ion, develop and follow image acquisition protocols, ensure
ata completeness, and apply reliability standards to the
maging procedure itself. Quality also requires that we
easure intraobserver and interobserver variability, con-
tantly seek correlative data, and use online standard images
o guide how we interpret recorded images.
Finally, we must identify the key data elements in an
maging report, incorporate these into relational datasets,
nd establish and use uniform reporting structures so that
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ommunicated to providers and their patients. Timeliness of
eports is another critical characteristic of imaging quality.
hese processes must be underpinned by laboratory accred-
tation and personnel certification standards that include
ngoing monitoring and self improvement—not a one-time
eview.
As the ACC embraces these structures and processes, we
ust not lose sight of our core objectives—improving
uality and better patient care. Applying quality principles
nd developing quality standards for imaging will help us
nsure better outcomes, more accurate and cost-effective
iagnosis and treatment, and the best value for patients,
roviders, payers, and society. It will reduce duplicate
esting and lower health care costs. It will improve health
utcomes and result in higher rates of patient satisfaction.
Change demands explicit, bold action. Long after turf
attles are over and scope-of-practice issues have been
esolved, we still need to offer our patients the highestuality imaging in a responsible and accurate manner. Our
ommitment to our patients and our own professionalism
emands this of us. Health care quality is a matter of life
nd death: we cannot afford to get this wrong.
ddress correspondence to: Dr. Pamela S. Douglas, American
ollege of Cardiology, c/o Cathy Lora, 9111 Old Georgetown
oad, Bethesda, Maryland 20814-1699.
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